SARS-CoV-2 Vaccination for Patients with Inflammatory Bowel Diseases
Since IBD is often treated with immune-modifying therapies, questions have been raised recently by the introduction of COVID vaccines and whether it is recommended for patients with IBD to be vaccinated. Dr. Marla Dubinsky, co-director of the Susan and Leonard Feinstein IBD Clinical Center at Mount Sinai and Professor of Medicine and Pediatrics (Gastroenterology), and colleagues, evaluate the evidence with help from Mount Sinai virologist Florian Krammer, PhD.
